A peripheral neuropathy must always be considered in the differential diagnosis of localized parnesthesia, sensory loss, lower motor neurone paralysis and pain, especially if these symptoms are combined. The feasibility of this diagnosis will depend on anatomical considerations, hence the first classification should be anatomical but, as I have pointed out elsewhere (Simpson 1968), disease may be classified in several ways. Thus the clinician will first classify the neuropathies anatomically, then pathologically and finally etiologically. The 'best' classification depends on the reason for categorization. For treatment and prognosis the etiological classification is paramount, but the other methods also give valuable clues to causation.
Anatomical Classification
Mononeuropathy: Motor or sensory disorders restricted to the distribution ofa single nerve root, trunk or branch are likely to be due to a local lesion, usually an 'entrapment neuropathy' (Kopell & Thompson 1963) or spondylosis. Recurrent trauma from a crutch or occupational causes should be looked for. If mechanical factors can be excluded, ischemic neuropathy (diabetes mellitus; arteritis) should be considered, but true neuritis (diphtheria; leprosy) is extremely rare in this country. Mononeuritis multiplex: Serial or simultaneous occurrence of neuropathy limited to the territories of a few nerves has essentially the same causes but ischoemia is more probable (polyarteritis nodosa, rheumatoid neuropathy, systemic lupus erythem-atosus, giant cell arteritis and other 'collagen diseases'; diabetes mellitus). This is the most difficult type of polyneuropathy to recognize except in the early stages. Radiculoneuropathy: This common type, due to inflammation of nerve roots and intrathecal parts of spinal and cranial nerves, may be associated with myelitis. The protein content of the CSF rises to high levels in the course of one or two weeks then falls slowly. The cell count is usually unchanged but a lymphocytic reaction may occur.
Radiculoneuropathy may be localized to a group of spinal nerves as in acute brachial neuritis (neuralgic amyotrophy). Many cases occur spontaneously or after surgery; others follow upper respiratory infection or exanthematous disease; a few follow injection of serum. An allergic mechanism is postulated for all types.
A more widespread form, the Landry-Guillain-Barre syndrome, probably has a similar mechanism though it is rare to identify a first cause. Infectious mononucleosis is one of these. This syndrome, the most frequent type of polyneuropathy, is commonly termed acute infective polyneuritis though there is no evidence of viral invasion of nerves and a similar syndrome may be associated with other diseases such as diabetes mellitus or one of the 'autoimmune' disorders. At the onset there may be pain in the back, neck or abdomen spreading to the limbs and associated with tenderness of muscles and nerve trunks. This is soon followed by progressive numbness, paresthesix and weakness of lower motor neurone type. Motor fibres are mainly involved and sensory loss may be minimal, but 'glove and stocking' anesthesia may be the main feature. Paralysis, with wasting and areflexia, usually starts in the lower limbs but soon involves upper limbs. It may start distally or proximally. Facial paralysis is common and involvement of the IX, X and XI cranial nerves may endanger respira-16 9 291
tion. If death from ventilatory failure can be avoided the prognosis is excellent, but recurrent attacks may take place. Symmetrical peripheral neuropathy: Certain sensorimnotor neuropathies of subacute onset and slow progression involve the longest nerve fibres first and then progressively shorter ones, causing paresis and sensory loss ascending from the periphery, with transverse upper levels and no selective involvement of discrete nerve territories. This is the type of peripheral neuropathy which is characteristic of metabolic or toxic disorders. Nerve fibres show a differential susceptibility to these factors which is related to the fibre diameter and probably to other unknown parameters, so that there are a few characteristic clinical pictures (e.g. alcohol; arsenic; lead; thalidomide). Unfortunately the majority are not fibre-specific.
Pathological Classification
From the point of view of the pathologist the neuropathies may be classified according to the cell primarily involved, bearing in mind that a peripheral nerve is a complex biological system in which the axons are peripheral extensions of neurones with cell bodies in the cord or dorsal root ganglia. Myelin sheaths are laid down by Schwann cells. However, there is evidence that the neurone contributes to the myelin and that the Schwann cells also play a role in the maintenance of the distal axon. Perineural sheaths preserve a micro-environment which is necessary for nerve conduction and they constitute a bloodnerve barrier. This has important implications (Simpson 1964). The pathological aspects are discussed by Dr Thomas (p 295), but it will be seen from Table 1 that this classification cuts right across an etiological one. Furthermore, it would appear that one cause may result in different lesions according to circumstances. For instance, both axonal degeneration and segmental demyelination are found in acute porphyria or poisoning with lead or acrylamide. Indeed, the more closely one examines the parenchymatous neuropathies the more certainly one will find evidence of both processes. The dominant one may depend on secondary factors such as rate of accumulation of a toxic substance and the age of the patient (Fullerton 1966 , Simpson 1968 . A systemic disorder may be insufficient to cause failure of nerve function except at sites of compression, ischwmia, or defective blood-nerve barrier. The additive effect of nerve entrapment has been shown in diabetic neuropathy, myxoedema, Landry-Guillain-Barre syndrome and familial neuropathy (for references see Simpson 1968) .
Three important conclusions are: (1) The causation of a neuropathy may be multifactorial.
(2) A diseasein the nosological sensemay cause neuropathy of different histopathological types. (3) An obvious lesion such as an entrapment syndrome may only be secondary.
It follows that a purely anatomical or a pathological classification, based only on a histological examination of a biopsy specimen, has serious limitations and the same criticism can be made of electrophysiological studies which contribute only to these two types of classification (Simpson 1968). In the ultimate analysis the only satisfactory classification must be etiological.
Etiological Classification
Unfortunately it is in this field that there are few advances to report. It still remains true that fewer than half the neuropathies seen in the clinic can be attributed to an identified first cause. I have suggested that the neuropathies should be regarded as biochemical lesions of different parts of the biological system which constitute the nerve (Simpson 1962 (Simpson , 1964 . Identification of these lesions offers the only prospect for rational therapy. The biochemical lesions may be genetic (e.g. Charcot-Marie-Tooth syndrome; primary amyloidosis), acquired, or a combination of both (e.g. porphyric neuropathy). Metabolic disorders may be a deficiency (e.g. beri-beri) or, presumably, a surplus of some toxic metabolite (e.g. urtmic and hepatic neuropathy). Enzyme systems may also be blocked by extrinsic poisons such as arsenic or thalidomide. This possibility exists for a very wide range of chemicals used domestically, industrially and in therapeutics. It is obligatory to search carefully for poisoning, bearing in mind that susceptibility varies enormously and may be determined genetically (e.g. isoniazid). It is not valid, for instance, to dismiss a drug as a possible cause of neuropathy on the grounds that it is widely used with apparent impunity (e.g. thalidomide). The appearance of neuropathy may depend on circumstances affecting the metabolism or Sectioni ofPhysical Medicinie 293 excretion of the drug (e.g. isoniazid, nitrofurantoin) and the same principle may apply to normal metabolites. There is a whole field of protein metabolism which remains unexplored though possibly relevant to the neuropathies associated with carcinoma and the dysproteinamias (Simpson 1962) .
It would be impossible to survey all the toxic and metabolic neuropathies in a short paper and this is not the appropriate place to provide a detailed source of reference. Further information on chemical factors and on the general principles of treatment of the neuropathies can be obtained from Simpson (1962 Simpson ( , 1968 .
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Peripheral Neuropathy: Electrodiagnostic Aspects
The abnormalities which may occur as a result of peripheral nerve disorders are segmental demyelination of the nerve fibre sheath, and axonal degeneration. Demyelination produces a slowing of nerve conduction speed, whereas axonal degeneration declares itself more by producing patterns of denervation and falling-out of motor unit potentials on electromyography, so that these two electrodiagnostic techniques are useful in investigating this large group of disorders. Each method on its own, however, is unreliable and it is with the cause of inaccuracy in nerve conduction speed measurements that this communication is particularly concerned.
Present-day methods are similar to those quoted by DuBois-Reymond (1866): the peripheral nerve is stimulated at two well-separated points (Fig 1) , the muscle action potential is collected from the same site on each occasion and the speed of transmission of the nerve volley between these two points calculated by the formula AB/(Tp-Td), where AB is the distance between the two points of stimuLlation expressed in millimetres, Tp is the latency from the proximal point of stimulation and Td is the latency from the distal point of stimulation expresscd in milliseconds. The muscle action potential can be collected either by surface electrodes or by needle electrode, each method having its own particular advantages and disadvantages. This system whereby the latency is measured from the moment of stimulation to the very first deflection of the base line by the action potential measures the speed of the fastest conducting fibres only, and this point is of importance in that if only one or two fast conducting nerve fibres remain intact a normal reading will be obtained.
At the same time as the motor nerve fibres are stimulated so also are the sensory fibre components of the mixed peripheral nerve, and the antidromic volley of sensory nerve action potentials can be collected by surface electrodes on the finger and displayed on the oscilloscope simultaneously with the muscle action potential (Fig 2) . Alternatively, the digital nerves in the fingers can be stimulated electrically or mechanically and the orthodromic nerve action potential volley collected by surface or needle electrodes placed near the peripheral nerve trunk (Sears 1959). 
